Objectives This study was carried out to: (1) explore the views of pharmacists in Nigeria on the extension of prescribing authority to them and determine their willingness to be prescribers and (2) identify the potential facilitators and barriers to introducing pharmacist prescribing in Nigeria. Method An online cross-sectional survey was conducted from August to October 2014 among 775 pharmacists recruited from the Facebook group of the Pharmaceutical Society of Nigeria using a simple random technique. The questionnaire used for the survey was developed based on the review of the literature and previous qualitative studies conducted in Nigeria. The instrument was evaluated for content validity by two external pharmacy practice researchers and the reliability of items assessed using internal consistency tests. Data obtained from the survey were entered into SPSS v.22, and descriptive statistics were generated. Relationships between variables were evaluated using the chisquare test, and P < 0.05 was considered statistically significant. Key findings The response rate was 40.6% (315/775). Three hundred and six (97.1%) respondents agreed that pharmacists should be given prescribing authority. Of these 306, 295 (96.4%) were willing to be prescribers, and just over half of them (148/295; 50.2%) would prefer to prescribe in collaboration with medical doctors. Of those willing to be prescribers, 285 (96.6%) reported that they would need additional training. The most perceived areas of training needed were in the principles of differential diagnosis (81.4%), pathophysiology of diseases (74.0%) and interpretation of laboratory results (68.1%). Respondents identified increasing patients' access to care (308/315; 97.8%) and better utilisation of pharmacists' skills (307/315; 97.5%) as the most likely facilitators to pharmacist prescribing in Nigeria. On the other hand, resistance from the medical doctors (299/315; 94.9%) and pharmacists' inadequate skills in diagnosis (255/315; 81.0%) were perceived as the most likely barriers. Conclusion Pharmacist prescribing represents an opportunity to promote patients' access to care and the utilisation of pharmacists' skills in Nigeria. The majority of pharmacists showed a positive attitude towards pharmacist prescribing and were willing to be prescribers. The findings of this study could potentially contribute to future medicine prescribing policy and pharmacy practice in Nigeria.
Introduction
Prescribing to patients has traditionally been under the professional domain of doctors and dentists, until the introduction of non-medical prescribing (NMP) in some countries which allowed non-medical professionals including nurses, pharmacists, optometrists and physiotherapists to prescribe medicines. [1, 2] Nurse prescribing is the most prevalent form of NMP worldwide. Available data shows that Nurses have been authorised to prescribe in 22 countries including the United States of America (USA), United Kingdom (UK), Australia, New Zealand, Canada, Sweden, the Republic of Ireland, South Africa, Botswana, Kenya and Uganda. [1] Pharmacists are legally allowed to prescribe medicines in the United States, UK, Canada, New Zealand and Israel. [2, 3] However, a 2009 global survey of hospital pharmacy practice revealed that hospital pharmacists in 20 countries are involved in the prescribing of medicines under certain local arrangements in emergency situations. [4] For instance, in Anguilla and Argentina, designated pharmacists are allowed to prescribe narcotic analgesics to cancer patients in an emergency. [5] There are different models of pharmacist prescribing including independent, supplementary and collaborative prescribing models. [2] In the independent prescribing model, the pharmacist is independently and legally responsible for the assessment of patients with diagnosed or undiagnosed conditions and for his or her prescribing decisions. Supplementary and collaborative prescribing models have similar features as the prescribing pharmacist prescribes in partnership with an independent prescriber usually a doctor or dentist, who makes the diagnosis and initial treatment decisions. [2] However, in the supplementary prescribing model, prescribing by pharmacists including modification and continuation of therapy is achieved using a patient-specific clinical management plan (CMP). The CMP is agreed by the independent and supplementary prescribers as well as the patient. The scope of prescribing authority accorded to pharmacists differs from one country to another. For example, in the UK, pharmacists can prescribe any medicine within their area of competence except cocaine, dipipanone and diamorphine for treating addiction, [6] while in Alberta, Canada, pharmacists with additional prescribing authorisation can prescribe any medicines within their area of competence except those covered under the Controlled Drugs and Substances Act including narcotics. [7, 8] Despite the challenges associated with the implementation of pharmacist prescribing including opposition from doctors and limited evidence to demonstrate its effectiveness, [9] it is gradually being accepted and implemented internationally. For example, in Canada, pharmacist prescribing started in 2007 in the Alberta province, and by 2012, all the provinces except Quebec had granted prescribing authority to pharmacists. [8] Furthermore, pharmacists in many countries, where pharmacist prescribing has not been legalised, are keen in taking on an extended role in prescribing. For example, in an Australian survey, 83.9% of the 2592 pharmacists who participated in the study were in favour of a prescribing authority being extended to them. [10] The increase in the international recognition of pharmacist prescribing has been facilitated by the desire to ensure prompt patient access to prescription medicines and better utilisation of pharmacists' skills. [9] Various stakeholders including doctors, pharmacists, patients and policymakers have reported an increase in patients' access to treatment as a result of NMP. [11, 12] In addition, pharmacists have reported a positive impact on their role to include: enhanced job satisfaction; better use of their clinical skills; integration of pharmacists into the patient management team; and more autonomy and responsibility in patient management as a result of pharmacist prescribing. [11, 13] In Nigeria, only medical doctors, dentists and some designated nurses and community health workers in community-based primary health centres (PHCs) have the legal right to prescribe medicines. [14] However, prescribing by nurses and community health workers has been reported to be inappropriate for a number of reasons including lack of adherence to treatment guidelines and their inadequate knowledge of medicines. [15, 16] For example, prescribing antibiotics for the treatment of viral respiratory infections has been reported to be common. [15, 16] In hospitals in Nigeria, the general out-patient departments (GOPDs) serve as the entry points for most patients seeking medical help because of the lack of doctors in PHCs. [3, 17] These GOPDs function more or less like the general practitioner (GP) practices in the UK. Typically, a doctor in a GOPD in Nigeria has approximately 40-50 patient consultations per day because of the shortage of doctors. [17, 18] In addition, more than 50% of patients visiting GOPDs wait for between 1-3 h to see a doctor. [17, 18] As a result, access to prescription medicines in Nigeria can be seriously affected by the shortage of medical prescribers (four doctors per 10 000 people compared with 28 doctors per 10 000 people in the UK) including GPs and specialist physicians and long waiting times in hospitals. [15, 19] Pharmacists in Nigeria are highly educated professionals with expertise in medicines management. However, their expertise is not used effectively as their roles have not been expanded to a more clinical one. They mainly perform the traditional role of dispensing which could be handled by suitably trained pharmacy technicians as in other countries such as the UK. [20] Pharmacists in Nigeria have shown a willingness for expanded clinical roles including prescribing. [3, 21] Our qualitative study involving semi-structured interviews with 43 Nigerian stakeholders including policymakers, doctors, pharmacists and patient group representatives revealed strong support for the introduction of pharmacist prescribing in Nigeria by participants who were not doctors especially pharmacists. [3] However, the findings of this study cannot be generalised because of the small sample size. Therefore the aim of this study was to: (1) explore the views of pharmacists in Nigeria on the extension of prescribing authority to them and determine their willingness to be prescribers and (2) identify the potential facilitators and barriers to introducing pharmacist prescribing in Nigeria
Methods

Study design
A cross-sectional survey was conducted from September to October 2014 among pharmacists in Nigeria using an online self-completion questionnaire as the data collection instrument.
Ethical approval
Ethical approval for this study was granted by the School of Healthcare Research Ethics Committee, University of Leeds, UK and the Plateau State Specialist Hospital Health Research Ethics Committee, Nigeria.
Recruitment of participants
Participants were recruited from the Facebook group of the Pharmaceutical Society of Nigeria (PSN). PSN is the professional body for pharmacists in Nigeria. PSN's Facebook group had 5214 members at the time of this survey. Participants for both the pilot and main survey were recruited using a simple random technique. To achieve a random sample, a list of the members of the Facebook group was retrieved in alphabetical order and then numbered serially. Microsoft Excel 2010 was used to generate a list of non-repeated random numbers which were applied to the PSN's Facebook group list to recruit participants for the online survey. A sample of 695 pharmacists determined using the sample size formula for descriptive studies, described by Eng, [22] were invited to participate in the survey.
Questionnaire development
The questionnaire was informed by the review of the literature, and findings of our qualitative studies conducted with Nigerian stakeholders in relation to extending pharmacists' clinical roles to include prescribing. [3, 10, 23] It was evaluated for content validity through an iterative review process by two external academic pharmacy practice researchers. The first page of the online survey contained an introductory statement relating to the study. In addition, it contained information on consent and implications of participating in the study. Those who agreed to continue with the survey moved onto the next page which contained the survey questions. The survey was anonymised and consisted of 62 items which were divided into three sections.
The first section of the questionnaire had eight items and sought to obtain anonymous demographic details of respondents including gender, years of experience, area and place of practice. These data are needed to enable the statistical classification of respondents' views and test for relationships between participants' demographics and views. The second section sought participants' views on clinical pharmacy practice in Nigeria and had nine items. The third section contained 45 items measuring respondents' views on pharmacist prescribing in Nigeria including their preferred model, willingness to be prescribers, perceived areas of training needs and potential facilitators and barrier. Depending on the survey item, respondents were either asked to respond yes/no or complete a 5-point Likert scale (strongly agree, agree, unsure, disagree and strongly disagree) to indicate their level of agreement with a statement.
Piloting of questionnaire
The questionnaire was piloted in August 2014 among a separate sample of 80 pharmacists recruited from the PSN's Facebook group as described above for the main sample. These pharmacists were sent a message through Facebook inviting them to participate in the online pilot survey. Participants were asked to provide feedback to the researcher on any aspect of the survey including style, length, access to the online questionnaire and difficulty faced when completing the online survey. A follow-up message was sent after 2 weeks thanking those who had completed the survey and requesting those who were yet to participate to please do so.
Of the 80 pharmacists that were contacted for the pilot survey, 41 participants returned completed surveys. Reliability testing of the questionnaire was carried out using Chronbach's alpha (a). The internal consistency of the 25 items measuring the facilitators and barriers to granting prescribing authority to pharmacists in Nigeria was determined using SPSS and that gave an a value of 0.745. The Kuder-Richardson reliability coefficients (KR-20) of the 13 items measuring respondents' perceived areas of training need for pharmacist prescribing were 0.892. Based on the responses to the pilot, no further changes to the questionnaire were found to be necessary. Hence, the data collected were included in the overall results of this study. This was considered acceptable as participants were included in the pilot study based on the same inclusion criteria and sampling technique used for the main survey.
The main survey
The 695 pharmacists identified for the main survey were invited through a generic recruitment mail sent to their Facebook inbox. The mail contained the link to the survey hosted by the Bristol Online Survey (BOS).
Reminders were sent to all research participants, 2 weeks after they received the initial invitation mailing. An additional 3 weeks was allowed to collect responses following the reminder. The survey was closed at the end of October 2014.
Data analysis
The data collected in this study were imported from the BOS system into the IBM SPSS version 22 for data management and analysis. Descriptive statistics generated using SPSS were used to represent the demographic characteristics of respondents and their views including those on prescribing. Relationships between two variables were evaluated using chi-square test. In tests involving variables in which data were obtained on the 5-point Likert scale, respondents' views were rescaled into three categories (strongly agree/agree, unsure and disagree/strongly disagree). This rescaling was carried out because of the small sample size of the study. In addition, recategorising respondents' views into three (as opposed to five) in chisquare analysis minimise the probability of making type 2 error (failing to reject the null hypothesis even though there is a difference between the groups in the population) which is usually manifested when the sample size is small or when considering a small subgroup within a large survey. Furthermore, Fisher's exact test was used to determine statistical difference between groups in instances where the groups were small, particularly when the numbers of counts per cell in the contingency table were <5 in more than 20% of the cells. In all the chisquare and Fisher's exact tests conducted, a P-value of <0.05 was considered statistically significant.
Results
Response rate
Of the 695 pharmacists contacted for the main survey (which excluded the 80 already included in the pilot), 316 attempted to complete the survey, but only 274 surveys were completely filled while the remaining 42 were partially completed. The 42 partially completed surveys were unusable and, therefore, excluded from the study. Hence, the response rate for the main study was 39.4% (274/695). Adding the pilot surveys [pilot response rate of 51.3% (41/80)] to those obtained in the main study yielded an overall response rate of 40.6% (315/775). Table 1 presents a summary of the demographic characteristics of respondents. The majority of respondents were men (197/315; 62.5%), and a third had between 6 and 10 years of experience (105/315; 33.3%) as pharmacists. Twenty-eight (8.9%) respondents held a master's degree in clinical pharmacy. The majority of respondents were hospital pharmacists (190/315; 60.3%).
Demographics
Views on pharmacist prescribing and willingness to be prescribers
The results of this study revealed strong support for an extended role in prescribing for pharmacists in Nigeria. Three hundred and six (97.1%) respondents agreed that pharmacists should be given the authority to prescribe medicines. Of these, 96.4% (295/315) were willing to be prescribers. There was no significant difference (P = 0.547) between willingness of hospital (95.8%) and community (97.7%) pharmacists to be prescribers. Of those willing to be prescribers, half (148/295) would prefer to prescribe in collaboration with medical doctors (who would diagnose), while 10.5% (31/295) preferred independent prescribing. Just over one-third of these respondents (111/295; 37.6%) would prefer a combination of collaborative and independent prescribing. Prescribing from a limited drug formulary was the least preferred model of prescribing among respondents (5/295, 1.7%). The results showed no significant difference (P = 0.491) between hospital and community pharmacists in their preference for any of the prescribing models.
Perceived areas of training needs
The majority of respondents (285/295; 96.6%) who were willing to be prescribers reported that they would need additional training in order to become prescribers. In addition, all of these respondents strongly agreed or agreed that postgraduate clinical courses should be developed to prepare pharmacists for prescribing. The most perceived areas of training need were in the principles of differential diagnosis (81.4%), pathophysiology of diseases (74.0%) and interpreting laboratory results (68.1%). Medication adherence (25.6%) and communication skills (35.1%) were reported as areas of least training need (Figure 1 ).
Potential facilitators and barriers to pharmacist prescribing
Respondents' views in relation to the potential facilitators and barriers to granting prescribing authority to pharmacists in Nigeria are presented in Table 2 
Discussion
Overall, pharmacists showed a positive attitude towards the introduction of pharmacist prescribing in Nigeria. The majority of them supported it and were willing to be prescribers themselves. These findings confirm the qualitative study we conducted with Nigerian stakeholders where the majority of the pharmacists interviewed were strongly supportive of the granting of prescribing authority to them. [2] We consider this to be the first national survey that investigated pharmacists' views on the extension of their clinical roles to include prescribing in Nigeria. The initial design of the project was to recruit participants who were representatives of the pharmacists' population in Nigeria in order to ensure statistical generalisation of the study findings. However, it was not possible to obtain the email addresses of all the registered pharmacists (about 17 000) on the Pharmacists' Council of Nigeria list as many do not have their emails on the councils' database. Therefore, the population in which the respondents of this survey were drawn was a biased one because it excluded Nigerian pharmacists who were not members of the Facebook group of PSN. About 60% of those contacted for this survey did not participate in the study. This is likely to introduce a non-response bias in the findings of this survey. Also, a large proportion of those that responded to the survey were hospital pharmacists, and this could be a potential source of bias as respondents of this study might have been those more interested in pharmacist prescribing. Despite these limitations, this study has provided many avenues for future research including a larger national survey that would generate generalisable data and to investigate how best to prepare Nigerian pharmacists for a potential role in prescribing. Also, future surveys should investigate the views of other key stakeholders including medical doctors and patients, who are major players in driving medicines policies in Nigeria.
The strong support for pharmacist prescribing seen in this study is unsurprising in view of pharmacists' aspirations for better utilisation of their skills and enhanced clinical autonomy in their practice. These desires are believed to be achievable within the scope of practice of the pharmacist prescriber. [3, 11] Therefore, such perception would have influenced pharmacists' support for prescribing.
Many facilitators to pharmacist prescribing identified in this survey were linked to its potential benefits. A key benefit identified in this research is the potential of pharmacist prescribing to increase patients' access to care. Increasing patients' access to care is one of the key policy objectives of NMP including pharmacist prescribing in countries where it is being practiced including the UK and Canada. [1] Patients in some UK studies have reported an increase in access to care including perceived reduction in appointment delays as a result of NMP. [11, 24] This would be of great benefit to patients in Nigeria considering that many patients lack access to medical care as a result of shortage of medical practitioners. In addition, pharmacists' involvement in prescribing could potentially reduce doctors' workload or permit doctors to deal with more complex cases leaving routine or patients with prediagnosed, long-term conditions to be seen by the prescribing pharmacists.
Medical resistance was perceived by the majority of respondents (94.9%) as the most likely barrier to pharmacist prescribing. However, medical resistance is unlikely if pharmacists prescribe in collaboration with doctors. This is because the doctor still maintains the overall control of the prescribing process. In addition, the doctor in a collaborative prescribing arrangement sees the pharmacist as someone who enhances or complements the doctors' role and not doctors' substitute. In contrast, independent pharmacist prescribing may be viewed by doctors as an encroachment into their territory and, therefore, could attract resistance from doctors. Although the majority of participants of this survey including hospital and community pharmacists reported that they would prefer to prescribe in collaboration with doctors, collaborative prescribing is more likely to be successful within hospital settings in the Nigerian context. Unlike hospital pharmacists, there is currently no system in place to foster collaborative working relationships between doctors and community pharmacists. In addition, community pharmacists in Nigeria have no access to patients' medical records maintained by hospitals. As a result, these factors are likely to present a challenge to community pharmacist collaborative prescribing. A limited form of independent prescribing using approved formularies or standard treatment guidelines for minor conditions could be more appropriate for community pharmacy settings in Nigeria. This was the type of prescribing model authorised for community pharmacists in South Africa in order to fill geographical gaps in relation to access to medical prescribers in rural settings. [25] Previous studies in Nigeria have advocated a policy change to allow community pharmacists to treat minor disease conditions. [26, 27] Hence, utilising Nigerian community pharmacists in a similar manner to South Africa offers an opportunity to increase patients access to care particularly in communities underserved by primary care facilities.
The perceived areas of training need identified in this study, including training in the principles of differential diagnosis, confirm respondents' concerns that pharmacists' inadequate skills in diagnosis and clinical assessment could be potential barriers to introducing pharmacist prescribing in Nigeria. In many countries where pharmacists are legally allowed to prescribe, those intending to be prescribers are required to undergo additional training to enhance their competence in prescribing. Although training requirements vary across countries, the UK training model appears to be well established and has been evaluated for its appropriateness in meeting the training needs of prescribers. Many supplementary and independent pharmacist prescribers in the UK have reported that the prescribing courses they attended provided them with relevant knowledge and skills for their roles. In addition, the period of learning and practice under a medical prescriber was highly appreciated. [28, 29] The UK training curriculum for non-medical prescribers is based on a single framework that ensures that all prescribers irrespective of their professional background develop comparable set of competencies. [30] Developing a similar competency framework and using it to inform the training of prescribers in Nigeria would be beneficial. Such a competency framework would ensure that all prescribers in Nigeria attain a minimum level of competency in which they can safely and competently prescribe medicines within their jurisdiction.
Conclusion
Generally, pharmacists showed a positive attitude towards pharmacist prescribing as the majority of them supported it and were willing to be prescribers. However, many pharmacists noted that they will need additional training particularly in the aspects of the principles of differential diagnosis and pathophysiology of diseases to take on a prescribing role. This study has provided many avenues for future research including how best to prepare Nigerian pharmacists for a potential role in prescribing. Many pharmacists also viewed pharmacist prescribing as an opportunity to promote patients' access to care and the utilisation of pharmacists' skills in Nigeria. This finding has the potential to shape future medicine prescribing policy and pharmacy practice in Nigeria. Nevertheless, a number of barriers to introducing pharmacist prescribing in Nigeria were identified including medical opposition and pharmacists' inadequate skills in clinical assessment and diagnosis.
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